| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-08 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.21 | 7e-05 |